Liquid biopsies in myeloid malignancies

Area of Science:

• Oncology
• Hematology
• Molecular Diagnostics

Background:

• Hematologic malignancies are leading cancers in children and young adults.
• Current diagnostics, like bone marrow biopsy, are invasive and risky.
• Liquid biopsies present a minimally invasive alternative for diagnosis and monitoring.

Purpose of the Study:

• To explore the role of liquid biopsies in diagnosing and managing hematologic malignancies.
• To highlight noninvasive biomarkers for real-time molecular profiling.
• To discuss the application of liquid biopsies in understanding tumor progression and treatment response.

Main Methods:

• Review of current literature on liquid biopsy biomarkers.
• Focus on circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), microRNAs, and exosomes.
• Discussion of diagnostic and therapeutic implications.

Main Results:

• Liquid biopsies enable minimally invasive assessment of cancer markers.
• Key biomarkers include CTCs, ctDNA, microRNAs, and exosomes.
• These biomarkers facilitate real-time molecular profiling for personalized treatment.

Conclusions:

• Liquid biopsies show significant potential to improve diagnostic and therapeutic strategies for leukemia patients.
• Noninvasive biomarkers aid in understanding tumor progression, metastasis, and response to therapy.
• This approach offers a less debilitating alternative to traditional bone marrow sampling.